Tuesday, 25 September 2018

#ClinicalGastro2019 #Gastroenterology #Stomach #Ulcer
call for abstract #GI 

#Ulcers can also occur in part of the #intestine just beyond the stomach. These are known as #duodenal ulcers.

Signs and symptoms

The most common symptom of a stomach ulcer is a burning or gnawing pain in the centre of the tummy (abdomen).
But stomach ulcers aren't always painful and some people may experience other symptoms, such as indigestion, heartburn and feeling sick.
Read more about the symptoms of a stomach ulcer and diagnosing a stomach ulcer.
For more Visit : https://bit.ly/2jj4hPa
Abstract Submission : https://bit.ly/2Lm1yBd

Monday, 24 September 2018

#Hepatology #Hepatology
#Immunization #liver 
#ClinicalGastro2019
#Hepatitis refers to an #inflammatory condition of the liver. It’s commonly caused by a #viral infection, but there are other possible causes of hepatitis. These include #autoimmune hepatitis and hepatitis that occurs as a secondary result of #medications#drugs#toxins, and alcohol
For more visit : https://bit.ly/2jj4hPa

Sunday, 23 September 2018

#ClinicalGastro2019 #Gastroenterology #Hepatology #GIdisease 
Call for Abstract | Abstract Submission | Speaker slots are open .
Gastrointestinal diseases refer to diseases involving the gastrointestinal tract, namely the #esophagus#stomach, small intestine, large intestine and #rectum, and the accessory organs of digestion, the #liver#gallbladder, and #pancreas
For more visit : https://bit.ly/2jj4hPa


Saturday, 22 September 2018

#Gastroenterology #Hepatology #Bowel #Pancreas 
Speaker | Poster | Group participation Slots are open 
Call for abstract 
Conference page : https://gastro.cmesociety.com/
Abstract submission link : https://bit.ly/2Lm1yBd


Friday, 21 September 2018

Barrett's esophagus:


In Barrett's esophagus, tissue in the tube connecting your mouth and stomach (esophagus) is replaced by tissue similar to the intestinal lining.
Barrett's esophagus is often diagnosed in people who have long-term gastroesophageal reflux disease (GERD) — a chronic regurgitation of acid from the stomach into the lower esophagus. Only a small percentage of people with GERD will develop Barrett's esophagus.
Barrett's esophagus is associated with an increased risk of developing esophageal cancer. Although the risk is small, it's important to have regular checkups for precancerous cells (dysplasia). If precancerous cells are discovered, they can be treated to prevent esophageal cancer.

Symptoms

The tissue changes that characterize Barrett's esophagus cause no symptoms. The signs and symptoms that you experience are generally due to GERD and may include:
  • Frequent heartburn
  • Difficulty swallowing food
  • Less commonly, chest pain
Many people with Barrett's esophagus have no signs or symptoms.


Wednesday, 12 September 2018

#Gastroenterology #Hepatology #Bowel
Call for abstract | Speaker/Delegate | Poster | Group participation | Registration opens for Clinical Gastro 2019 
June 19-20, 2018 | London, UK
Visit : http://gastro.cmesociety.com/
Abstract submission : https://bit.ly/2Lm1yBd


Tuesday, 4 September 2018


Ulcerative colitis : 


Ulcerative colitis (UL-sur-uh-tiv koe-LIE-tis) is an inflammatory bowel disease (IBD) that causes long-lasting inflammation and ulcers (sores) in your digestive tract. Ulcerative colitis affects the innermost lining of your large intestine (colon) and rectum. Symptoms usually develop over time, rather than suddenly.
Ulcerative colitis can be debilitating and can sometimes lead to life-threatening complications. While it has no known cure, treatment can greatly reduce signs and symptoms of the disease and even bring about long-term remission.

Symptoms

Ulcerative colitis symptoms can vary, depending on the severity of inflammation and where it occurs. Signs and symptoms may include:
  • Diarrhea, often with blood or pus
  • Abdominal pain and cramping
  • Rectal pain
  • Rectal bleeding — passing small amount of blood with stool
  • Urgency to defecate
  • Inability to defecate despite urgency
  • Weight loss
  • Fatigue
  • Fever
  • In children, failure to grow

Causes

The exact cause of ulcerative colitis remains unknown. Previously, diet and stress were suspected, but now doctors know that these factors may aggravate but don't cause ulcerative colitis.
One possible cause is an immune system malfunction. When your immune system tries to fight off an invading virus or bacterium, an abnormal immune response causes the immune system to attack the cells in the digestive tract, too.
Heredity also seems to play a role in that ulcerative colitis is more common in people who have family members with the disease. However, most people with ulcerative colitis don't have this family history.
Visit : https://bit.ly/2mIEceL



Wednesday, 29 August 2018

            Exocrine pancreatic insufficiency (EPI)

         It is the inability to properly digest food due to a lack of digestive enzymes made by               the pancreas. EPI is found in humans afflicted with cystic fibrosis and Shwachman–              Diamond syndrome

         What are the symptoms of exocrine pancreatic insufficiency?
  • Frequent diarrhea. EPI can cause problems with undigested food moving too quickly through the digestive tract.
  • Gas and bloating. ...
  • Stomach pain. ...
  • Foul-smelling, greasy stools (steatorrhea) ...
  • Weight loss.

    How do you test for pancreatic insufficiency?
  1. Fecal elastase test. This test measures the amount of elastase, an enzyme produced by the pancreas, in your stool. ...
  2. Fecal fat test. This test checks the amount of fat in your stool. ...
  3. Direct pancreatic function test.

Symptoms and Signs :

  • anemia (Vitamin B12, iron, folate deficiency)
  • bleeding disorders (Vitamin K malabsorption)
  • edema (hypoalbuminemia)
  • fatigue
  • flatulence and abdominal distention (bacterial fermentation of unabsorbed food)
  • hypocalcemia
  • metabolic bone disease (Vitamin D deficiency)
  • neurologic manifestation
  • steatorrhea
  • weight loss


For more visit : https://bit.ly/2jj4hPa
Abstract submission : https://bit.ly/2Lm1yBd






Tuesday, 28 August 2018

Hepatocellular Carcinoma (HCC)


Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer in adults, and is the most common cause of death in people with cirrhosis.
It occurs in the setting of chronic liver inflammation, and is most closely linked to chronic viral hepatitis infection (hepatitis B or C) or exposure to toxins such as alcohol or aflatoxin. Certain diseases, such as hemochromatosis and alpha 1-antitrypsin deficiency, markedly increase the risk of developing HCC. Metabolic syndrome and NASH are also increasingly recognized as risk factors for HCC.
As with any cancer, the treatment and prognosis of HCC vary depending on the specifics of tumor histology, size, how far the cancer has spread, and overall health.
The vast majority of HCC occurs in Asia and sub-Saharan Africa, in countries where hepatitis B infection is endemic and many are infected from birth. The incidence of HCC in the United States and other developing countries is increasing due to an increase in hepatitis C virus infections. It is more common in males than females for unknown reasons

Most cases of HCC occur in people who already have signs and symptoms of chronic liver disease. They may present either with worsening of symptoms or may be without symptoms at the time of cancer detection. HCC may directly present with yellow skin, abdominal swelling due to fluid in the abdominal cavity, easy bruising from blood clotting abnormalities, loss of appetite, unintentional weight loss, abdominal pain, nausea, vomiting, or feeling tired

Diagnosis:
Methods of diagnosis in HCC have evolved with the improvement in medical imaging. The evaluation of both asymptomatic patients and those with symptoms of liver disease involves blood testing and imaging evaluation.

For more visit : 
https://bit.ly/2mIEceL



Monday, 27 August 2018

Recent Advancement in Gastroenterology 

Endoscopic Ultrasound Stomach LiverGutpancreas 
Endoscopic ultrasound (EUS) is a minimally invasive procedure to assess digestive (gastrointestinal) and lung diseases. A special endoscope uses high-frequency sound waves to produce detailed images of the lining and walls of your digestive tract and chest, nearby organs such as the #pancreas and liver, and lymph nodes.

    How long does it take to do an endoscopic ultrasound?
Because the pancreas sits next to the stomach and small intestine, EUS allows the physician to get very detailed images of the pancreas. This procedure is typically performed in an outpatient setting, and usually takes between 20 and 45 minutes.
What is the difference between an endoscopy and an endoscopic ultrasound?
An endoscopic ultrasound is a lot different than an endoscopy, even though they sound the same. An endoscopic ultrasound is inserted with a flexible tube down the esophagus with an ultrasound attached. ... The difference in this and anendoscopy, is the ultrasound uses sound waves to capture the images

For more visit : https://bit.ly/2mIEceL


Saturday, 25 August 2018

gastrointestinal stromal tumor (GIST) is a type of tumor that occurs in the gastrointestinal tract, most commonly in the stomach or small intestine. The tumors are thought to grow from specialized cells found in the gastrointestinal tract called interstitial cells of Cajal (ICCs) or precursors to these cells. GISTs are usually found in adults between ages 40 and 70; rarely, children and young adults develop these tumors. The tumors can be cancerous (malignant) or noncancerous (benign).
Small tumors may cause no signs or symptoms. However, some people with GISTs may experience pain or swelling in the abdomen, nausea, vomiting, loss of appetite, or weight loss. Sometimes, tumors cause bleeding, which may lead to low red blood cell counts (anemia) and, consequently, weakness and tiredness. Bleeding into the intestinal tract may cause black and tarry stools, and bleeding into the throat or stomach may cause vomiting of blood.

Is gist cancer curable?

In nearly all patients, there is no apparent reason why GIST has developed. ... In fact, patients with metastatic GIST treated with imatinib mesylate now have a 2 year survival of about 80% from the time of metastasis. The prognosis of a patient with primary GIST depends on tumor size, location, and cellular division.


For More visit : https://bit.ly/2mIEceL


# ClinicalGastro2019   # Gastroenterology   # Stomach   # Ulcer call for abstract  # GI   # Ulcers  can also occur in part of the  # intest...